Home NDC 55150-128 Oxacillin
Product NDC 55150-128
11-digit product format 551500128
Labeler code 55150
Product ID 55150-128_0570fa17-5fe7-4647-9dde-d6097388a4e8
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Oxacillin Sodium
Dosage form INJECTION, POWDER, FOR SOLUTION
Route INTRAMUSCULAR; INTRAVENOUS
Labeler Eugia US LLC
Application ANDA201539
Marketing category ANDA
Marketing start 2013-01-18
Substance OXACILLIN SODIUM
Active strength 2 g/1
Pharmacologic classes Penicillin-class Antibacterial [EPC], Penicillins [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 55150-128-25 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 55150-128-25 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 55150-128-25 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 55150-128-25 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 55150-128-25 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 55150-128-25 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 55150-128-25 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 55150-128-25 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 55150-128-25 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 55150-128-25 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 55150-128-25 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 55150-128-25 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A201539-001 OXACILLIN SODIUM OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 A201539-002 OXACILLIN SODIUM OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A201539-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A201539-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2013-01-18 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Oxacillin
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength OXACILLIN SODIUM 2 g/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination G0V6C994Q5 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1743547 Internal RxNorm lookup 1743549 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 55150-128-24 Oxacillin 10 in 1 BOX INJECTION, POWDER, FOR SOLUTION 10 11 55150-128-24 Oxacillin 1 in 1 VIAL INJECTION, POWDER, FOR SOLUTION 1 11
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded OXACILLIN SODIUM ACTIVE INGREDIENT G0V6C994Q5 OXACILLIN (OXACILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION OXACILLIN (OXACILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [AUROMEDICS PHARMA LLC] 4 OXACILLIN ACTIVE MOIETY UH95VD7V76 OXACILLIN (OXACILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION OXACILLIN (OXACILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [AUROMEDICS PHARMA LLC] 4 SODIUM PHOSPHATE, DIBASIC INACTIVE INGREDIENT GR686LBA74 OXACILLIN (OXACILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION OXACILLIN (OXACILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [AUROMEDICS PHARMA LLC] 4 OXACILLIN SODIUM ACTIVE INGREDIENT G0V6C994Q5 OXACILLIN (OXACILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [AUROMEDICS PHARMA LLC] 1 OXACILLIN ACTIVE MOIETY UH95VD7V76 OXACILLIN (OXACILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [AUROMEDICS PHARMA LLC] 1 SODIUM PHOSPHATE, DIBASIC INACTIVE INGREDIENT GR686LBA74 OXACILLIN (OXACILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [AUROMEDICS PHARMA LLC] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 55150-128 OXACILLIN (OXACILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION OXACILLIN (OXACILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [EUGIA US LLC] 10 Current NDC, Legacy NDC, 2 package rows 20230203_81e90279-9889-47bd-974b-334c181f295c.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 55150-128-24 55150012824 10 VIAL in 1 BOX (55150-128-24) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL 10 vial 2013-01-18 0000-00-00 No No Current